132 related articles for article (PubMed ID: 16178350)
1. Blood schizontocidal activity of azithromycin and its combination with alpha/beta arteether against multi-drug resistant Plasmodium yoelii nigeriensis, a novel MDR parasite model for antimalarial screening.
Tripathi R; Dhawan S; Dutta GP
Parasitology; 2005 Sep; 131(Pt 3):295-301. PubMed ID: 16178350
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
[TBL] [Abstract][Full Text] [Related]
3. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Puri SK; Singh N
Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis.
Dutta GP; Bajpai R; Vishwakarma RA
Pharmacol Res; 1989; 21(4):415-9. PubMed ID: 2771860
[TBL] [Abstract][Full Text] [Related]
6. New orally active diphenylmethyl-based ester analogues of dihydroartemisinin: Synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
Chaudhary S; Naikade NK; Tiwari MK; Yadav L; Shyamlal BRK; Puri SK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1536-1541. PubMed ID: 26898813
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of antimalarial activity of arteether in combination with Vetiver root extract.
Dhawan S; Gunjan S; Pal A; Tripathi R
Indian J Exp Biol; 2016 May; 54(5):315-21. PubMed ID: 27319050
[TBL] [Abstract][Full Text] [Related]
8. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
Tripathi R; Pandey SK; Rizvi A
Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
[TBL] [Abstract][Full Text] [Related]
10. Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo.
Tripathi R; Jefford CW; Dutta GP
Parasitology; 2006 Jul; 133(Pt 1):1-9. PubMed ID: 16764736
[TBL] [Abstract][Full Text] [Related]
11. Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice.
Singh C; Chaudhary S; Puri SK
Bioorg Med Chem Lett; 2008 Feb; 18(4):1436-41. PubMed ID: 18206370
[TBL] [Abstract][Full Text] [Related]
12. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
Singh C; Malik H; Puri SK
J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
[TBL] [Abstract][Full Text] [Related]
13. New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice.
Singh C; Chaudhary S; Puri SK
J Med Chem; 2006 Nov; 49(24):7227-33. PubMed ID: 17125275
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
Neerja J; Puri SK
Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
[TBL] [Abstract][Full Text] [Related]
15. Novel hydrazone derivatives of N-amino-11-azaartemisinin with high order of antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in Swiss mice via intramuscular route.
Karnatak M; Hassam M; Singh AS; Yadav DK; Singh C; Puri SK; Verma VP
Bioorg Med Chem Lett; 2022 Feb; 58():128522. PubMed ID: 34974111
[TBL] [Abstract][Full Text] [Related]
16. Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Bhardwaj J; Siddiqui AJ; Goyal M; Prakash K; Soni A; Puri SK
Acta Trop; 2016 Jun; 158():130-138. PubMed ID: 26925772
[TBL] [Abstract][Full Text] [Related]
17. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ; Alhomida AS
In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
[TBL] [Abstract][Full Text] [Related]
18. Haem polymerase as a novel target of antimalarial action of cyproheptadine.
Agrawal R; Tripathi R; Tekwani BL; Jain SK; Dutta GP; Shukla OP
Biochem Pharmacol; 2002 Nov; 64(9):1399-406. PubMed ID: 12392821
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial interaction of quinine and quinidine with clarithromycin.
Pandey SK; Dwivedi H; Singh S; Siddiqui WA; Tripathi R
Parasitology; 2013 Mar; 140(3):406-13. PubMed ID: 23137860
[TBL] [Abstract][Full Text] [Related]
20. New functionalized 1,2,4-trioxepanes: synthesis and antimalarial activity against multi-drug resistant P. yoelii in mice.
Singh C; Pandey S; Kushwaha AK; Puri SK
Bioorg Med Chem Lett; 2008 Oct; 18(19):5190-3. PubMed ID: 18789862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
